Jaguar Health achieves statistically significant top line results in crofelemer study
Jaguar Health announced that statistically significant top line results have been achieved in a key preclinical pharmacological study to evaluate effects of crofelemer on diarrhea induced in healthy dogs by a maximally tolerated dose of a specific tyrosine kinase inhibitor. August 19, 2019